A Plain Language Summary of Results from the GARNET Study of Dostarlimab in Patients with Endometrial Cancer.

Ana Oaknin,Lucy Gilbert,Anna V Tinker,Jubilee Brown,Cara Mathews,Joshua Press,Renaud Sabatier,David M O'Malley,Vanessa Samouelian,Valentina Boni,Linda Duska,Sharad Ghamande,Prafull Ghatage,Rebecca Kristeleit,Charles Leath,Yuping Dong,Jennifer Veneris,Bhavana Pothuri

Future oncology (London, England)（2023）

引用 0|浏览30

暂无评分

摘要

The results of the GARNET study led to being approved to treat patients with certain types of endometrial cancer. For patients with advanced-stage endometrial cancer, or endometrial cancer that has come back after chemotherapy (recurrent), there are few treatment options. The results suggest that may provide long-term benefits for these patients. NCT02715284 (ClinicalTrials.gov).

查看译文

关键词

endometrial cancer,dostarlimab,garnet study

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要